Verastem (VSTM) Stock Forecast & Price Target

$3.90 -0.06 (-1.52%)

(As of 01:00 PM ET)

Verastem - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 8 Analyst Ratings

Sell
0

Hold
0

Buy
8

Based on 8 Wall Street analysts who have issued ratings for Verastem in the last 12 months, the stock has a consensus rating of "Buy." Out of the 8 analysts, 8 have given a buy rating for VSTM.

Consensus Price Target

$12.00
207.69% Upside

According to the 8 analysts' twelve-month price targets for Verastem, the average price target is $12.00. The highest price target for VSTM is $20.00, while the lowest price target for VSTM is $7.00. The average price target represents a forecasted upside of 207.69% from the current price of $3.90.

Get the Latest News and Ratings for VSTM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Verastem and its competitors.

VSTM Analyst Ratings Over Time

Type	Current Forecast 12/25/23 to 12/24/24	1 Month Ago 11/25/23 to 11/24/24	3 Months Ago 9/26/23 to 9/25/24	1 Year Ago 12/25/22 to 12/25/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	7 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$12.00	$12.50	$14.83	$29.71
Forecasted Upside	207.69% Upside	212.50% Upside	464.01% Upside	259.74% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Pocket $1,100 in 60 Seconds per Day with AI? (Ad)

What if I told you 60 seconds a day could completely change your life?

My AI-powered trading system finds high-probability option trades in less than 60 seconds a day

Click HERE to access this powerful AI Trading System

VSTM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

VSTM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Verastem Stock vs. The Competition

Type	Verastem	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.81	2.51
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	210.88% Upside	26,388.02% Upside	13.93% Upside
News Sentiment Rating	Neutral News See Recent VSTM News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/19/2024	Mizuho 3 of 5 stars		Boost Target	Outperform ➝ Outperform	$7.00 ➝ $9.00	+111.27%
12/19/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$7.00 ➝ $7.00	+64.32%
10/18/2024	Royal Bank of Canada 4 of 5 stars		Reiterated Rating	Outperform ➝ Outperform	$13.00 ➝ $13.00	+392.42%
10/18/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight
9/30/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Schmidt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$13.00	+383.27%
8/13/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$18.00 ➝ $15.00	+525.00%
Get the Latest News and Ratings for VSTM and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verastem and its competitors with MarketBeat's FREE daily newsletter.
7/24/2024	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$21.00 ➝ $7.00	+135.69%
5/29/2024	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Molloy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$34.00 ➝ $20.00	+383.09%
11/21/2023	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$27.00	+318.60%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 01:43 PM ET.

VSTM Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Verastem is $12.00, with a high forecast of $20.00 and a low forecast of $7.00.
: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Verastem in the last twelve months. There are currently 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" VSTM shares.
: According to analysts, Verastem's stock has a predicted upside of 207.69% based on their 12-month stock forecasts.
: Verastem has been rated by research analysts at Cantor Fitzgerald, Guggenheim, HC Wainwright, Mizuho, and Royal Bank of Canada in the past 90 days.
: Analysts like Verastem more than other "medical" companies. The consensus rating for Verastem is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how VSTM compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Forced out of retirement by these trades (Ad)

You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changed

Make sure to check out Gamma Pockets HERE while it’s still widely available

This page (NASDAQ:VSTM) was last updated on 12/24/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Verastem (VSTM) Stock Forecast & Price Target